Both medications may initially cause nausea or intestinal discomfort, but these symptoms usually subside after a few weeks

Patent Information: 2026 Novo Nordisk (semaglutide) Tablets 1.5 mg Rx only DISPENSE WITH MEDICATION GUIDE Note to Pharmacist: Individual strengths of semaglutide are not substitutable on a mg-to-mg basis New Formulation of semaglutide 30 tablets (semaglutide) Tablets 4 mg Rx only DISPENSE WITH MEDICATION GUIDE Note to Pharmacist: Individual strengths of semaglutide are not substitutable on a mg-to-mg basis New Formulation of semaglutide 30 tablets (semaglutide) Tablets 9 mg Rx only DISPENSE WITH MEDICATION GUIDE Note to Pharmacist: Individual strengths of semaglutide are not substitutable on a mg-to-mg basis New Formulation of semaglutide 30 tablets (semaglutide) Tablets 3 mg Once daily Oral use only Rx only DISPENSE WITH MEDICATION GUIDE 30 tablets (semaglutide) Tablets 7 mg Once daily Oral use only Rx only DISPENSE WITH MEDICATION GUIDE 30 tablets (semaglutide) Tablets 14 mg Once daily Oral use only Rx only DISPENSE WITH MEDICATION GUIDE 30 tablets (semaglutide) Tablets 3 mg Once daily Each tablet contains 3 mg semaglutide Oral use only Rx only Dispense the Enclosed Medication Guide to Each Patient 30 tablets 3 blister packs

this study also looked at liraglutide, the active ingredient in Saxenda and Victoza, which are also GLP-1 agonists
The same finding had been reported by a prior larger meta-analysis (6,914 patients with overweight or obesity and T2DM) over 8 studies 184,185,189,190,191,192,193,194 , but only when the largest study that also included non-diabetic participants 193 was excluded in a sensitivity analysis 195
A broad range of clinically relevant long-term outcomes were assessed against an active comparison group, DPP4i, in a relatively large sample size, and statistical methods were used to address potential confounding and bias